James I Cameron1, Pamela A Pulido2, Julie C McCauley2, William D Bugbee3. 1. Greenville Health System, Steadman Hawkins Clinic of the Carolinas, Greenville, South Carolina, USA. 2. Shiley Center for Orthopaedic Research and Education at Scripps Clinic, La Jolla, California, USA. 3. Division of Orthopaedic Surgery, Scripps Clinic, La Jolla, California, USA Bugbee.william@scrippshealth.org.
Abstract
BACKGROUND: Osteochondral allograft (OCA) transplantation is a recognized treatment modality for cartilage damage in the knee. Few reports are available on outcomes of OCA in the patellofemoral joint, and there are no reports on lesions isolated to the femoral trochlea. PURPOSE: To evaluate graft survivorship and clinical outcomes in patients who had an OCA to the femoral trochlea. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: An OCA database was used to identify 29 knees in 28 patients (mean age, 30.2 years; range, 12-47 years; 8 female, 20 male) who were treated with a fresh OCA transplant limited to the femoral trochlea. The primary outcome was graft survivorship, and the minimum follow-up was 2 years. Clinical outcomes were assessed by the modified Merle d'Aubigné-Postel (18-point) score; Knee Society function (KS-F) score; International Knee Documentation Committee (IKDC) pain, function, and total scores; and University of California, Los Angeles (UCLA) activity score. The OCA patient satisfaction score (5-point scale from extremely satisfied to dissatisfied) was also reported. RESULTS: The mean follow-up period was 7.0 years (range, 2.1-19.9 years). Graft survivorship was 100% at 5 years and 91.7% at 10 years. One patient was converted to a total knee arthroplasty 7.6 years after OCA surgery. The mean modified Merle d'Aubigné-Postel score improved from 13.0 to 16.1, the mean KS-F score from 65.6 to 85.2, and the mean IKDC total score from 38.5 to 71.9; the mean UCLA score was 7.9 postoperatively. Eighty-nine percent of patients were extremely satisfied or satisfied with the outcome of surgery. CONCLUSION: Fresh OCA transplantation resulted in excellent clinical outcomes in this patient cohort with articular cartilage damage to the femoral trochlea. The procedure resulted in improved pain and function and high patient satisfaction.
BACKGROUND: Osteochondral allograft (OCA) transplantation is a recognized treatment modality for cartilage damage in the knee. Few reports are available on outcomes of OCA in the patellofemoral joint, and there are no reports on lesions isolated to the femoral trochlea. PURPOSE: To evaluate graft survivorship and clinical outcomes in patients who had an OCA to the femoral trochlea. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: An OCA database was used to identify 29 knees in 28 patients (mean age, 30.2 years; range, 12-47 years; 8 female, 20 male) who were treated with a fresh OCA transplant limited to the femoral trochlea. The primary outcome was graft survivorship, and the minimum follow-up was 2 years. Clinical outcomes were assessed by the modified Merle d'Aubigné-Postel (18-point) score; Knee Society function (KS-F) score; International Knee Documentation Committee (IKDC) pain, function, and total scores; and University of California, Los Angeles (UCLA) activity score. The OCA patient satisfaction score (5-point scale from extremely satisfied to dissatisfied) was also reported. RESULTS: The mean follow-up period was 7.0 years (range, 2.1-19.9 years). Graft survivorship was 100% at 5 years and 91.7% at 10 years. One patient was converted to a total knee arthroplasty 7.6 years after OCA surgery. The mean modified Merle d'Aubigné-Postel score improved from 13.0 to 16.1, the mean KS-F score from 65.6 to 85.2, and the mean IKDC total score from 38.5 to 71.9; the mean UCLA score was 7.9 postoperatively. Eighty-nine percent of patients were extremely satisfied or satisfied with the outcome of surgery. CONCLUSION: Fresh OCA transplantation resulted in excellent clinical outcomes in this patient cohort with articular cartilage damage to the femoral trochlea. The procedure resulted in improved pain and function and high patient satisfaction.
Authors: Ryan M Degen; Nathan W Coleman; Danielle Tetreault; Brenda Chang; Greg T Mahony; Christopher L Camp; Shawn G Anthony; Riley J Williams Journal: Cartilage Date: 2016-08-24 Impact factor: 4.634
Authors: Central South University National Clinical Research Center For Geriatric Disorders Xiangya Hospital Journal: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi Date: 2021-01-15
Authors: Joshua I Wright-Chisem; Matthew R Cohn; Kyle N Kunze; Adam Wright-Chisem; Tyler Warner; Justin J Hicks; Riley J Williams Journal: Cartilage Date: 2020-11-27 Impact factor: 3.117
Authors: Renato Andrade; Joni Nunes; Betina B Hinckel; Jordan Gruskay; Sebastiano Vasta; Ricardo Bastos; J Miguel Oliveira; Rui L Reis; Andreas H Gomoll; João Espregueira-Mendes Journal: Cartilage Date: 2019-12-17 Impact factor: 3.117
Authors: Betina B Hinckel; Dimitri Thomas; Evan E Vellios; Kyle John Hancock; Jacob G Calcei; Seth L Sherman; Claire D Eliasberg; Tiago L Fernandes; Jack Farr; Christian Lattermann; Andreas H Gomoll Journal: Cartilage Date: 2021-03-20 Impact factor: 3.117
Authors: Mark E Cinque; Nicholas I Kennedy; Gilbert Moatshe; Gustavo Vinagre; Jorge Chahla; Zaamin B Hussain; Robert F LaPrade Journal: Arthrosc Tech Date: 2017-09-25
Authors: Simon Görtz; Suzanne M Tabbaa; Deryk G Jones; John D Polousky; Dennis C Crawford; William D Bugbee; Brian J Cole; Jack Farr; James E Fleischli; Alan Getgood; Andreas H Gomoll; Allan E Gross; Aaron J Krych; Christian Lattermann; Bert R Mandelbaum; Peter R Mandt; Raffy Mirzayan; Timothy S Mologne; Matthew T Provencher; Scott A Rodeo; Oleg Safir; Eric D Strauss; Christopher J Wahl; Riley J Williams; Adam B Yanke Journal: Orthop J Sports Med Date: 2021-03-23